Pharma and life sciences products are designed under constraints that most digital categories never meet. A clinical trial platform, a medical affairs portal, a patient support app, and a field-force CRM all handle sensitive data, serve users with very different levels of expertise, and sit inside processes where a design mistake can delay a study or compromise patient safety. Design here is not decoration on top of a workflow — it is part of how the workflow stays compliant, auditable, and understandable.
User diversity is extreme. The same organisation may need to serve clinical researchers reading dense datasets, sales representatives working between hospital visits on a phone, and patients managing a chronic condition at home, often with limited digital confidence or physical limitations. Each group needs a different information density, tone, and interaction model, and the design has to respect accessibility standards and, for older patients, real constraints on vision, dexterity, and attention.
Regulatory and technical complexity finishes the picture. Validated systems, GxP expectations, data privacy rules such as HIPAA and GDPR, promotional review processes, and long integration chains with legacy clinical and ERP systems all shape what can be shipped and how fast. The agencies that do this well combine design craft with a working knowledge of the regulatory environment, so that design decisions survive review rather than being unwound by it.
IDEO brings human-centred research to health and life sciences, grounding patient and clinician products in real behaviour rather than assumption.
Best for: Patient-centred research, healthcare service and product strategy
frog links design to business strategy, useful for pharma organisations building digital health products and connected experiences.
Best for: Digital health strategy, connected products, innovation programmes
Fjord's service design roots suit life sciences journeys that span clinics, homes, and digital tools, backed by Accenture's delivery scale.
Best for: Service-integrated health design, large-scale delivery
Designit combines strategic design with technology delivery and has a long-standing health and life sciences focus across Europe and Asia.
Best for: Health service design, multi-market digital programmes
Deloitte Digital pairs UX with regulatory and technology transformation expertise, suited to enterprise life sciences programmes.
Best for: Regulated enterprise transformation, validated system UX
Huge applies data and personalisation strength to health brands, particularly patient engagement and consumer-facing health products.
Best for: Patient engagement, data-driven health experiences
NetBramha's strength is taking complicated, rule-bound products and making them legible. Their Petrofac engagement involved operational tools for professional users working under strict safety and process requirements — the same discipline that clinical operations and quality teams in life sciences rely on. The design work centred on information hierarchy, error prevention, and workflows that reflect how regulated teams actually work.
Their Yubi platform work shows the handling of dense, high-stakes data for institutional users, and their HDFC mobile banking design shows how they build trust into products where privacy, security, and clarity are non-negotiable. These are transferable strengths for pharma teams building portals, dashboards, and patient-facing tools.
The product is a data-dense, regulated platform — their work on financial and operational systems maps well to clinical, quality, and supply-chain dashboards.
Trust and privacy must be visible in the interface — their fintech and banking work builds credibility into every interaction.
You need one team from research to design system — their end-to-end process avoids handoff loss between strategy and execution.
Pharma-specific portfolio depth — their case studies are in adjacent regulated sectors, so confirm relevant life sciences experience and regulatory review familiarity.
Clinical-grade validation requirements — for validated GxP systems, confirm how design deliverables fit your documentation and change-control process.
“NetBramha knows what they are doing and very clear and concise in their thought process.”Executive, Online Newspaper Portal · Bengaluru, India · 2022
“I don't think we'd have done as well as we did if not for NetBramha Studios.”Aditya Mishra · Founder & CEO, SwitchMe · Mumbai, India · May 2020
IDEO's human-centred methodology suits life sciences because so many health products fail on real-world behaviour rather than on features. Their research with patients, caregivers, and clinicians surfaces the barriers — adherence, understanding, trust — that shape whether a therapy support programme or digital tool is actually used.
They also work at the systems level, connecting a digital product to the clinical service and organisational process around it. That breadth is valuable when the question is not just what to design but what to build at all.
Patient behaviour is poorly understood — their ethnographic research reveals what actually drives adherence and engagement.
The product spans clinical and digital touchpoints — their systems thinking covers the whole service.
Strategy must precede design — they help define the right problem before solutions are built.
Speed to production — their thorough process may not fit compressed timelines.
Detailed UI execution — confirm capacity for production-grade design systems and specifications.
frog integrates design with business and technology strategy, which suits pharma companies moving beyond the pill into digital therapeutics, companion apps, and connected devices. Their teams can shape the product concept, the business case, and the experience together.
Their large-enterprise experience helps in organisations where medical, legal, regulatory, and commercial stakeholders all need alignment before anything ships.
You are building a new digital health offering — their strategy and design combination helps shape viable products.
Hardware and software must work together — their connected product experience covers devices and companion apps.
Executive alignment is a challenge — their consulting posture works at senior levels.
Narrow, execution-only projects — their model tends to expand toward strategy.
Regional market research — confirm local capability outside their core markets.
Fjord treats a health product as one part of a wider service — the clinic visit, the pharmacy, the call centre, the home. That perspective produces experiences that fit real care journeys rather than living as isolated apps.
Being part of Accenture Song gives them a path from design into technology delivery and change management, useful for large pharma rollouts across many markets.
The journey spans physical and digital touchpoints — service design is their core strength.
Delivery must scale globally — Accenture's reach supports multi-market programmes.
Regulated constraints shape the design — they have experience across health and public sector.
Senior attention throughout — confirm staffing seniority on your engagement.
Design-only scope — their model leans toward broader delivery.
Designit brings strategic design and technology together and has built a long track record in healthcare and life sciences across Europe and Asia. Their teams handle the research-to-delivery arc for patient and provider experiences.
As part of Wipro, they also connect design to engineering capacity, which helps when a concept needs to become a production system.
Multiple regions must be served — their international studios support multi-market work.
Design must flow into engineering — Wipro's capacity supports build.
Service and product design are both needed — they work across both layers.
Boutique-level exclusivity — confirm the team assigned and how it is staffed.
Specific therapy area knowledge — ask for directly relevant examples.
Deloitte Digital connects UX to the compliance, technology, and change management work that large life sciences organisations need. Their regulated-industry experience means design recommendations account for validation, privacy, and governance from the start.
They suit programmes where UX is one workstream inside a wider platform or CRM transformation.
UX sits inside a system implementation — they manage design alongside technology delivery.
Compliance shapes every decision — their regulated experience reduces late-stage surprises.
Multiple business units are involved — they coordinate large programmes.
Boutique craft — large consultancies vary in design seniority.
Standalone design scope — confirm whether design can be contracted separately.
Huge combines design with data and personalisation, which is valuable for patient engagement, adherence programmes, and consumer-facing health brands. Their work is grounded in behavioural data at scale.
They are strongest where a brand already has audiences and data to work with, and less suited to first-of-kind clinical tools.
Personalisation drives the experience — they design around data from the start.
A consumer health brand needs a digital flagship — they know large brand programmes.
Behavioural data is available — their analytics inform design decisions.
Clinical or validated tools — confirm their experience with regulated clinical workflows.
New products without existing data — their approach relies on data availability.
Do they understand your regulatory environment? Ask how design decisions are documented and reviewed alongside medical, legal, and regulatory processes. An agency that has never worked inside a review cycle will lose time you cannot recover.
Who are the actual users? Clinicians, patients, sales teams, and researchers need very different designs. Ask each agency how they research and test with each group, and how they recruit participants in a sensitive domain.
How do they handle accessibility? Patient-facing products serve older users and people with conditions that affect vision, dexterity, and cognition. Ask for accessibility standards they design to and how they test against them.
Can they work with your existing systems? Life sciences platforms integrate with validated legacy systems. Ask how the agency designs within technical constraints and collaborates with your engineering and quality teams.
What do they deliver beyond screens? Design systems, specifications, and rationale documentation make the work reviewable and maintainable. Ask to see examples of handoff artefacts from similar projects.
How much does pharma and life sciences UX design cost?
A focused engagement for a single portal or app typically runs $50,000–$150,000. A full programme covering research, design, and a design system for a regulated platform typically runs $150,000–$500,000, depending on validation and integration requirements.
Should I use a specialist or generalist agency?
A specialist helps when regulatory review and clinical workflows dominate the project. A strong generalist with regulated-industry experience can work well when the main challenge is complex data and workflow design, provided they involve your compliance teams early.
How long does a pharma and life sciences UX project take?
Focused projects typically take 10–16 weeks. Full platform programmes take 6–12 months, and review and approval cycles often add time that should be planned from the start.
UX practice and digital product expectations differ by region — what signals quality and trust to a buyer in the US or UK is different from Dubai or Singapore. An agency with direct market experience brings depth that cross-industry portfolios cannot substitute.
UX & Enterprise Industry Hub →
